Browse All

Current Filters

CLEAR FILTER x

TITLE

Topic:

Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study

Author:Croop, Robert   Ailani, Jessica   Kudrow, David   Smith, Timothy   Lipton, Richard   Thiry, Alexandra   Jensen, Christopher   Kamen, Lisa   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.010  

Author Institution:Biohaven Pharmaceuticals , Wynnewood, PA  Medstar Georgetown Neurology, McLean, VA  David Kudrow MD, Los Angeles, CA  Study Metrix Research, Saint Peters, MO  Albert Einstein College of Medicine, Bronx, NY  Biohaven Pharmaceuticals, New Haven, CT  

Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine

Author:Mullin, Kathleen   Pavlovic, Jelena   Hutchinson, Susan   Lipton, Richard   Jensen, Christopher   Thiry, Alexandra   Kamen, Lisa   Croop, Robert   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.011  

Author Institution:New England Institute for Neurology and Headache, Stamford, CT  Albert Einstein College of Medicine, Bronx, NY  Orange County Migraine & Headache Center, Irvine, CA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Wynnewood, PA  

Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors

Author:Best, Patricia   Harriott, Andrea   Monteith, Teshamae   Tassorelli, Cristina   Nahas, Stephanie   Liu, Yingyi   Dabruzzo, Brett   De Abreu Ferreira, Rosa   Smith, Jonathan H.   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.012  

Author Institution:Mayo Clinic, Rochester, MN  Massachusetts General Hospital, Boston, MA  University of Miami, Miami, FL  University of Pavia, Pavia, Italy  Thomas Jefferson University, Philadelphia, PA  AbbVie, Madison, NJ  AbbVie, Frederick, MD  AbbVie, Canidelo, Portugal  AbbVie, North Chicago, IL  

A Cross-Sectional Survey of Prevailing Opinions from Headache Specialists Regarding Status Migrainosus Management

Author:Robblee, Jennifer   Vann, Robert   Fitzpatrick, Christopher   Murphy, Michelle   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P11: Headache: Evaluating Paradigms for Optimal Outcomes  

Topic:Headache  

Program Number:P11.001  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  Impel Pharmaceuticals, Seattle, WA  Impel Pharmaceuticals, Studio City, CA  

Botulinum Toxin Off Label Use in Chronic Migraine Patients: An American Headache Society Clinical Survey Study

Author:Ali, Ashhar   Davis, Kendra   Mathew, Paul   

Session Name:P11: Headache: Evaluating Paradigms for Optimal Outcomes  

Topic:Headache  

Program Number:P11.002  

Author Institution:Henry Ford, Bloomfield Twp, MI  Henry Ford Hospital, Detroit, MI  Harvard Medical School/BWH/HVMA, Braintree, MA